文献速递类风湿关节炎其他结缔组织病

MUC5B启动子变异与间质性肺病及类风湿关节炎发病时间的关联

Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

在Mass General Brigham Biobank中纳入1005例符合2010 ACR/EULAR标准的类风湿关节炎(RA)患者,分析MUC5B启动子变异(rs35705950 G>T)与RA相关间质性肺病(RA-ILD)及RA发病时间的关联。MUC5B启动子变异与RA-ILD(OR 3.34)、RA诊断前或诊断后2年内发生RA-ILD(OR 4.01)及55岁后发病的RA(OR 1.52)相关。作者认为该变异可能影响RA病程早期的RA-ILD风险,尤其在晚发型RA患者中。

要点

  • MUC5B启动子变异与RA-ILD风险相关,多变量OR 3.34(95%CI 1.97, 5.60)。
  • 该变异与RA诊断前或诊断后2年内发生RA-ILD相关,OR 4.01(95%CI 1.78, 8.80)。
  • 该变异与55岁后发病的RA相关,OR 1.52(95%CI 1.08, 2.12)。

核心结论

  • 常见MUC5B启动子变异与RA-ILD在RA病程中较早发生及RA发病年龄较晚相关。
  • 作者认为MUC5B启动子变异可能影响RA病程早期的RA-ILD风险,尤其在晚发型RA患者中。

研究设计与样本

  • 在Mass General Brigham Biobank这一多医院生物样本与临床数据收集研究中,识别符合2010 ACR/EULAR标准且有基因型信息的RA患者。
  • 通过查阅所有有CT影像、肺活检或尸检结果的RA患者确定RA-ILD是否存在,并通过人工病历回顾确定RA和RA-ILD诊断日期。
  • 采用多变量logistic回归估计MUC5B启动子变异状态对各结局的OR,并校正包括遗传祖先和吸烟在内的潜在混杂因素。
  • 共纳入1005例有rs35705950基因型数据的RA患者,平均年龄45岁,79%为女性,81%为欧洲祖先。

主要发现

  • MUC5B启动子变异见于155例(15.4%)RA患者。
  • MUC5B启动子变异与RA-ILD相关,多变量OR 3.34(95%CI 1.97, 5.60)。
  • MUC5B启动子变异与RA诊断前或诊断后2年内发生RA-ILD相关,OR 4.01(95%CI 1.78, 8.80)。
  • MUC5B启动子变异与55岁后发病的RA相关,OR 1.52(95%CI 1.08, 2.12)。

关键数值与推荐

  • RA-ILD:MUC5B启动子变异多变量OR 3.34(95%CI 1.97, 5.60)。
  • RA诊断前或诊断后2年内发生RA-ILD:MUC5B启动子变异OR 4.01(95%CI 1.78, 8.80)。
  • 55岁后发病的RA:MUC5B启动子变异OR 1.52(95%CI 1.08, 2.12)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the associations of the common MUC5B promoter variant with timing of RA-associated interstitial lung disease (RA-ILD) and RA onset. METHODS: We identified patients with RA meeting 2010 ACR/EULAR criteria and available genotype information in the Mass General Brigham Biobank, a multihospital biospecimen and clinical data collection research study. We determined RA-ILD presence by reviewing all RA patients who had CT imaging, lung biopsy or autopsy results. We determined the dates of RA and RA-ILD diagnoses by manual records review. We examined the associations of the MUC5B promoter variant (G>T at rs35705950) with RA-ILD, RA-ILD occurring before or within 2 years of RA diagnosis and RA diagnosis at age >55 years. We used multivariable logistic regression to estimate odds ratios (ORs) for each outcome by MUC5B promoter variant status, adjusting for potential confounders including genetic ancestry and smoking. RESULTS: We identified 1005 RA patients with available genotype data for rs35705950 (mean age 45 years, 79% female, 81% European ancestry). The MUC5B promoter variant was present in 155 (15.4%) and was associated with RA-ILD [multivariable OR 3.34 (95% CI 1.97, 5.60)], RA-ILD before or within 2 years of RA diagnosis [OR 4.01 (95% CI 1.78, 8.80)] and RA onset after age 55 years [OR 1.52 (95% CI 1.08, 2.12)]. CONCLUSIONS: The common MUC5B promoter variant was associated with RA-ILD onset earlier in the RA disease course and older age of RA onset. These findings suggest that the MUC5B promoter variant may impact RA-ILD risk early in the RA disease course, particularly in patients with older-onset RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. McDermott G, Gill R, Gagne S, et al. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset. Rheumatology (Oxford). 2022. PMID: 35289841. doi:10.1093/rheumatology/keac152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。